---
schema_version: "secwatch.filing_event.v1"
accession: "0001739104-26-000027"
form_type: "8-K"
ticker: "ELAN"
cik: "0001739104"
company_name: "Elanco Animal Health Inc"
filed_at: "2026-05-06T23:59:59+00:00"
generated_at: "2026-05-14T22:49:30.530688+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Elanco Q1 revenue +15% to $1.37B, raises FY2026 guidance across all metrics

## Summary
- Q1 revenue $1.37B (+15% reported, +10% organic constant currency); adjusted EPS $0.40 vs $0.37 prior year.
- Full-year 2026 guidance raised: revenue $5,010-$5,085M, adj. EBITDA $975-$1,005M, adj. EPS $1.03-$1.09.
- Q2 2026 guidance: revenue $1,300-$1,325M, adj. EBITDA $240-$260M, adj. EPS $0.25-$0.28.
- Innovation revenue target raised to $1.2B; net leverage target improved to 3.0x-3.2x.
- Credelio Quattro and Zenrelia post strong share gains; closed AHV International acquisition Apr 30.

## SEC filing metadata
- accession: 0001739104-26-000027
- form_type: 8-K
- ticker: ELAN
- cik: 0001739104
- company_name: Elanco Animal Health Inc
- filed_at: 2026-05-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739104/000173910426000027/0001739104-26-000027-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739104/000173910426000027/elan-20260506.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001739104-26-000027
- JSON: https://secwatch.observer/filing/0001739104-26-000027.json
- Plain text: https://secwatch.observer/filing/0001739104-26-000027.txt

## Key facts
- Earnings Releases
  Elanco Animal Health Inc reported first quarter of 2026 results: revenue $1,371 million, net income $57 million, EPS $0.11. Guidance raised.
  - Period: first quarter of 2026
  - Revenue: $1,371 million
  - Net income: $57 million
  - EPS: $0.11
  - Guidance: raised
  - Result: reported results
  source text: First Quarter 2026 Results Raising Full Year Outlook and Innovation Target, Improving Year-End Net Leverage Ratio Target • First Quarter 2026 Financial Results: ◦ Revenue of $1,371 million, an increase of 15% year-o ver-ye ar; 10% organic constant currency growth ◦ Reported Net Income of $57 million, Adjusted Net Income of $204 million ◦ Adjusted EBITDA of $334
  evidence_url: https://www.sec.gov/Archives/edgar/data/1739104/000173910426000027/0001739104-26-000027-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.